Comparison of an overnight switch to everolimus-based immunosuppression versus continuation of ciclosporin-based immunosuppression in renal transplant recipients

Trial Profile

Comparison of an overnight switch to everolimus-based immunosuppression versus continuation of ciclosporin-based immunosuppression in renal transplant recipients

Not stated
Phase of Trial: Phase IV

Latest Information Update: 28 Sep 2011

At a glance

  • Drugs Ciclosporin; Everolimus; Immunosuppressants
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Sep 2011 New trial record
    • 07 Sep 2011 Results presented at the 15th Congress of the European Society for Organ Transplantation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top